Researcher, Douglas Institute
bruno_dot_giros_At_mcgill_dot_ca |
2012
Bacq A., Balasse L., Biala G., Guiard B., Gardier A. M., Schinkel A., Louis F., Vialou V., Martres M. P., Chevarin C., Hamon M., Giros B., Gautron S. (2012). Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response, Mol Psychiatry, 17(9), 926-39. Find out more.
Baudin A., Blot K., Verney C., Estevez L., Santamaria J., Gressens P., Giros B., Otani S., Dauge V., Naudon L. (2012). Maternal deprivation induces deficits in temporal memory and cognitive flexibility and exaggerates synaptic plasticity in the rat medial prefrontal cortex, Neurobiol Learn Mem, 98(3), 207-14. Find out more.
Berthet A., Bezard E., Porras G., Fasano S., Barroso-Chinea P., Dehay B., Martinez A., Thiolat M. L., Nosten-Bertrand M., Giros B., Baufreton J., Li Q., Bloch B., Martin-Negrier M. L. (2012). L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor, J Neurosci, 32(2), 681-91. Find out more.
El Khoury M. A., Gorgievski V., Moutsimilli L., Giros B., Tzavara E. T. (2012). Interactions between the cannabinoid and dopaminergic systems: Evidence from animal studies, Prog Neuropsychopharmacol Biol Psychiatry, 38(1), 36-50. Find out more.
Farley S., Dumas S., El Mestikawy S., Giros B. (2012). Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801, Neuropharmacology, 62(1), 503-17. Find out more.
Fournet V., Schweitzer A., Chevarin C., Deloulme J. C., Hamon M., Giros B., Andrieux A., Martres M. P. (2012). The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances, J Neurochem, 121(1), 99-114. Find out more.
Fournet V., de Lavilleon G., Schweitzer A., Giros B., Andrieux A., Martres M. P. (2012). Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice, J Neurochem, 123(6), 982-96. Find out more.
Haenisch B., Drescher E., Thiemer L., Xin H., Giros B., Gautron S., Bonisch H. (2012). Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3, Naunyn Schmiedebergs Arch Pharmacol, 385(10), 1017-23. Find out more.